Overview

An Open-Label Study of N-Acetyl Cysteine in Children With Autism

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test the tolerability and efficacy of N-Acetyl Cysteine (NAC) in children with Autism.
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Treatments:
Acetylcysteine
N-monoacetylcystine